e. esin Et Al. , "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results," ESMO 2018 Congress , 2018
esin, e. Et Al. 2018. Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results. ESMO 2018 Congress .
esin, e., ÇAKMAK ÖKSÜZOĞLU, Ö. B., BİLİCİ, A., ÇİÇİN, İ., AKSOY, S., ALACACIOĞLU, A., ... KAPLAN, M. A.(2018). Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results . ESMO 2018 Congress
esin, ece Et Al. "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results," ESMO 2018 Congress, 2018
esin, ece Et Al. "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results." ESMO 2018 Congress , 2018
esin, e. Et Al. (2018) . "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results." ESMO 2018 Congress .
@conferencepaper{conferencepaper, author={ece esin Et Al. }, title={Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results}, congress name={ESMO 2018 Congress}, city={}, country={}, year={2018}}